Product mentioned on podcasts
Retrotide
by Eli Lilly
Mentioned on 1 episode by 1 guest across our covered podcasts.
SignalCast may earn commission on purchases via these links. As an Amazon Associate, SignalCast earns from qualifying purchases.
Who mentioned it
“Dr. Tatem revealed that Retrotide, Lilly's forthcoming triple-receptor GLP-1 drug targeting GLP-1, GIP, and glucagon simultaneously, has already been self-administered by bodybuilders and biohackers for two years via research-use-only markets”
Mentioned on: The Diary of a CEO